← back to search

Voravit Ratanatharathorn

The Barbara Ann Karmanos Cancer Institute · US
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, and Lymphoma Diagnosis and Treatment.
h-index
36
citations
6,844
works
228
NIH funding
primary concept
Medicine
email

Recent publications

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Transplantation and Cellular Therapy 2022cited by 53position: middledoi
National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Journal of Clinical Oncology 2021cited by 210position: middledoi
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
The Lancet Oncology 2016cited by 918position: middledoi
Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
Blood 2016cited by 48position: middledoi
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation 2016cited by 26position: middledoi
Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation 2014cited by 59position: middledoi
High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantation Patients
Biology of Blood and Marrow Transplantation 2014cited by 52position: middledoi
Effect of HLA-Matching Recipients to Donor Noninherited Maternal Antigens on Outcomes after Mismatched Umbilical Cord Blood Transplantation for Hematologic Malignancy
Biology of Blood and Marrow Transplantation 2012cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathon B. Cohen · Emory University2 papers (2016–2016)Kerry J. Savage · BC Cancer Agency2 papers (2016–2016)Margaret A. Shipp · Harvard University2 papers (2016–2016)Kazunobu Kato · Lemuel Shattuck Hospital2 papers (2016–2016)Lawrence G. Lum · Southwestern Medical Center2 papers (2014–2014)Abhinav Deol · Wayne State University2 papers (2014–2014)Philippe Armand · Harvard University2 papers (2016–2016)Muneer H. Abidi · Michigan State University2 papers (2014–2014)Andreas Engert · Integrated Oncology (United States)2 papers (2016–2016)Scott J. Rodig · Massachusetts Institute of Technology2 papers (2016–2016)Stephen M. Ansell · Toyota Motor Corporation (Switzerland)2 papers (2016–2016)John M. Timmerman · UCLA Medical Center2 papers (2016–2016)Anas Younes · Intercept Pharmaceuticals (United States)2 papers (2016–2016)John Kuruvilla · University of Toronto2 papers (2016–2016)Michelle A. Fanale · Pfizer (United States)2 papers (2016–2016)Zaid Al‐Kadhimi · University of Alabama at Birmingham2 papers (2014–2014)Marek Trněný · O2 Czech Republic (Czechia)2 papers (2016–2016) · 2 papers (2014–2014)Armando Santoro · Humanitas University2 papers (2016–2016)Graham P. Collins · Churchill Hospital2 papers (2016–2016)